Your browser doesn't support javascript.
loading
Outcomes of Interferon/Ribavirin Therapy in Patients with HCV Defined by Expression of Plasma Soluble Human Leukocyte Antigen-G but Not IL-37.
Ding, Shi-xiong; Ma, Jian-bo; Hu, Yao-ren; Hu, Ai-rong; Shen, Qiang; Gao, Guo-shen.
Afiliação
  • Ding SX; Department of Laboratory Medicine, The Affiliated Ningbo No. 2 Hospital, College of Medicine, Ningbo University, Ningbo, Zhejiang, China (mainland).
  • Ma JB; Department of Laboratory Medicine, The Affiliated Ningbo No. 2 Hospital, College of Medicine, Ningbo University, Ningbo, Zhejiang, China (mainland).
  • Hu YR; Institute of Liver Disease, The Affiliated Ningbo No. 2 Hospital, College of Medicine, Ningbo University, Ningbo, Zhejiang, China (mainland).
  • Hu AR; Institute of Liver Disease, The Affiliated Ningbo No. 2 Hospital, College of Medicine, Ningbo University, Ningbo, Zhejiang, China (mainland).
  • Shen Q; Institute of Liver Disease, The Affiliated Ningbo No. 2 Hospital, College of Medicine, Ningbo University, Ningbo, Zhejiang, China (mainland).
  • Gao GS; Department of Laboratory Medicine, The Affiliated Ningbo No. 2 Hospital, College of Medicine, Ningbo University, Ningbo, Zhejiang, China (mainland).
Med Sci Monit ; 22: 1398-402, 2016 Apr 26.
Article em En | MEDLINE | ID: mdl-27112970

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribavirina / Interleucina-1 / Interferon-alfa / Hepatite C Crônica / Antígenos HLA-G Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribavirina / Interleucina-1 / Interferon-alfa / Hepatite C Crônica / Antígenos HLA-G Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article